In addition to breast cancer, Zhang et al. (2019) reported that A-FABP, along with Il-FABP, can be developed as a potential biomarker for detecting colorectal cancer because they are expressed at high levels in colorectal cancer patients compared to healthy individuals. Here, FABP4 is linked to breast cancer.